This study is novel as it reports a significantly higher co-localization of TRPM7 with actin in the ME/CFS cohort following NS8593 treatment compared with the NTB condition for ME/CFS and the NS8593 condition for HC. This evidence concerns the gene TRPM7 and myalgic encephalomeyelitis/chronic fatigue syndrome.